High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 1, 2007, Pages 84-91

  Huang, Maosheng ^a   Dinney, Colin P ^a   Lin, Xin ^a   Lin, Jie ^a   Grossman, H Barton ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLASE MUTY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR PROTEIN; PROTEIN APEX1; PROTEIN OGG1; PROTEIN XRCC1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXCISION REPAIR; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ALGORITHMS; CELL CYCLE; DNA REPAIR; EPIDEMIOLOGY, MOLECULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 33846580207     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0712     Document Type: Article

References (36)

1. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung, and breast. J Intern Med 2001;249:477-93.
2. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
3. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-9.
4. Barrett JC. Mechanisms of action of known human carcinogens [review]. IARC Sci Publ 1992;116:115-34.
5. Hoover RN. Cancer-nature, nurture, or both. N Engl J Med 2000;343:135-6.
6. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
7. MacMahon B. Gene-environment interactions in human disease. J Psychiatr Res 1968;6:393-402.
8. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
9. Doll R. Cancers related to smoking. Proceedings Second World Conference on Smoking and Health. London: Pitman Medical; 1971. p. 10-23.
10. Petrovich Z, Baert L, Boyd SD, et al. Management of carcinoma of the bladder [review]. Am J Clin Oncol 1998;21:217-22.
11. Ward EM, Sabbioni G, DeBord DG, et al. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J Natl Cancer Inst 1996;88:1046-52.
12. Wilson DM III, Thompson LH. Life without DNA repair. Proc Natl Acad Sci U S A 1997;94:12754-7.
13. Friedberg EC, McDaniel LD, Schultz RA. The role of endogenous and exogenous DNA damage and mutagenesis [review]. Curr Opin Genet Dev 2004;14:5-10.
14. Zhang H, Singer B. Recursive partitioning in the health sciences. New York: Springer; 1999.
15. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-47.
16. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-82.
17. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003;24:150-7.
18. Moore JH. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 2004;4:795-803.
19. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006;241:252-61.
20. Rossner P, Jr., Terry MB, Gammon MD, et al. OGG1S326C polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:811-5.
21. 326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 2005;229:85-91.
22. Takezaki T, Gao CM, Wu JZ, et al. hOGG1S326C Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 2002;99:624-7.
23. 326 variant, allelic imbalance of chromosome band 3p25.3, and TP53 mutations in ovarian cancer. Int J Oncol 2005;27:1315-20.
24. Chevillard S, Radicella JP, Levalois C, et al. Mutations in OGG1S326C, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 1998;16:3083-6.
25. Kim EJ, Jeong P, Quan C, et al. Genotypes of TNF-α, VEGF, hOGG1S326C, GSTM1, and GSTT1:useful determinants for clinical outcome of bladder cancer. Urology 2005;65:70-5.
26. 399Gln, in Japanese lung cancer risk. Carcinogenesis 2004;25:1395-401.
27. Terry PD, Umbach DM, Taylor JA. APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking. Int J Cancer 2006;118:3170-3.
28. 399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1337-41.
29. Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 2003;12:1234-40.
30. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-34.
31. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
32. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-31.
33. Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:939-43.
34. Zhang Z, Miao XP, Tan W, Guo YL, Zhang XM, Lin DX. Correlation of genetic polymorphisms in DNA repair genes ADPRT and XRCC1 to risk of gastric cancer. Ai Zheng 2006;25:7-10.
35. Matsumoto Y. Molecular mechanism of PCNA-dependent base excision repair. Prog Nucleic Acid Res Mol Biol 2001;68:129-38.
36. Andrew AS, Nelson HH, Kelsey KT, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking, and bladder cancer susceptibility. Carcinogenesis 2006;27:1030-7.